Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction

REVIEW

Chappel, S. C., & Howles, C. M. (1991) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137513 · Cited by 280

Nongenomic effects of 17 beta-estradiol on maturing human oocytes: relationship to oocyte developmental potential

Tesařík, J., & Mendoza, C. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.4.7714121 · Cited by 247

The role of luteinizing hormone in folliculogenesis and ovulation induction

Filicori, M. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00482-8 · Cited by 171

Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients

Shoham, Z., Balen, A. H., Patel, A. K., & Jacobs, H. S. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54715-3 · Cited by 170

Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone

Fleming, R., Lloyd, F., Herbert, M., Fenwick, J., Griffiths, T., & Murdoch, A. P. (1998) · Human Reproduction · doi:10.1093/humrep/13.7.1788 · Cited by 160

Endocrinology: The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone

Balasch, J., Miró, F., Burzaco, I., Casamitjana, R., Cı́vico, S., Ballescà, J. L., Puerto, B., & Vanrell, J. A. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136154 · Cited by 151

Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome

Loumaye, E., Engrand, P., Howles, C. M., & O'Dean, L. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81402-1 · Cited by 142

Characteristics of human follicular fluid associated with successful conception after in vitro fertilization.

Andersen, C. Y. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.5.7521343 · Cited by 137

Studies of the mechanism(s) of mammalian ovulation

Yoshimura, Y., & Wallach, E. E. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)49931-0 · Cited by 114

Serum Luteinizing Hormone Concentrations Increase 100-Fold in Females From 7 Years of Age to Adulthood, as Measured by Time-Resolved Immunofluorometric Assay

Apter, D. L., Cacciatore, B., Alfthan, H. V., & Stenman, U. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-1-53 · Cited by 110

Gonadotropin-Releasing Hormone And Reproductive Medicine

Shalev, E., & Leung, P. C. K. (2003) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30206-7 · Cited by 31

Randomized trial comparing luteinizing hormone supplementation timing strategies in older women undergoing ovarian stimulation

Behre, H. M., Howles, C. M., & Longobardi, S. (2015) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2015.06.002 · Cited by 30

A prospective, randomized, controlled trial comparing three different gonadotropin regimens in oocyte donors: ovarian response, in vitro fertilization outcome, and analysis of cost minimization

de Melo, M. A. B., Bellver, J., Garrido, N., Meseguer, M., Pellicer, A., & Remohi, J. A. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.05.005 · Cited by 30

Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration

Propst, A. M., Hill, M. J., Bates, G. W., Palumbo, M., Horne, A. K. V., & Retzloff, M. G. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.06.069 · Cited by 30

Recombinant luteinizing hormone supplementation to recombinant follicle-stimulation hormone during induced ovarian stimulation in the GnRH-agonist protocol: A meta-analysis

Oliveira, J. B. A., Mauri, A. L., Petersen, C. G., Martins, A. M. C., Cornicelli, J., Cavanha, M., Pontes, A., Baruffi, R. L. R., & Franco, J. G., Jr. (2006) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-006-9095-4 · Cited by 30

Anti-Müllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF/ICSI cycles: a prospective, multi-centre, observational study

Li, R., Gong, F., Zhu, Y., Fang, W., Yang, J., Liu, J., Hu, L., Yang, D., Liang, X., & Qiao, J. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.07.003 · Cited by 29

"hCG priming" effect in controlled ovarian stimulation through a long protocol

Beretsos, P., Partsinevelos, G. A., Arabatzi, E., Drakakis, P., Mavrogianni, D., Anagnostou, E., Stefanidis, K., Antsaklis, A. J., & Loutradis, D. (2009) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-7-91 · Cited by 29

Understanding the role of LH: myths and facts

Fischer, R. (2007) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60375-6 · Cited by 29

No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part I, corifollitropin alfa

Doody, K. J., Devroey, P., Leader, A., Witjes, H., & Mannaerts, B. M. J. L. (2011) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2011.06.015 · Cited by 27

Direct impact of gonadotropins on glucose uptake and storage in preovulatory granulosa cells: Implications in the pathogenesis of polycystic ovary syndrome

Chahal, N., Geethadevi, A., Kaur, S., Lakra, R., Nagendra, A., Shrivastav, T. G., Pascali, F. D., Reiter, É., Crépieux, P., Devi, M. G., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154458 · Cited by 26

Efficacy of a combined protocol of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle

Pacchiarotti, A., Aragona, C., Gaglione, R., & Selman, H. A. (2007) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-007-9159-0 · Cited by 26

Follicular fluid hormonal profile and cumulus cell gene expression in controlled ovarian hyperstimulation with recombinant FSH: effects of recombinant LH administration

Barberi, M., Ermini, B., Morelli, M. B., Ermini, M., Cecconi, S., & Canipari, R. (2012) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-012-9893-9 · Cited by 25

Recombinant LH in ovarian stimulation

Çağlar, G. S., Asimakopoulos, B., Nikolettos, N., Diedrich, K., & Al‐Hasani, S. (2005) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61123-6 · Cited by 25

Oral contraceptive pretreatment in women undergoing controlled ovarian stimulation in ganirelix acetate cycles may, for a subset of patients, be associated with low serum luteinizing hormone levels, reduced ovarian response to gonadotropins, and early pregnancy loss

Meldrum, D. R., Scott, R. T., Levy, M. J., Alper, M. M., & Noyes, N. L. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.01.007 · Cited by 25

Mifepristone Is an Effective Oral Alternative for the Prevention of Premature Luteinizing Hormone Surges and/or Premature Luteinization in Women Undergoing Controlled Ovarian Hyperstimulation forin VitroFertilization

Escudero, E., Boerrigter, P. J., Bennink, H. J. T. C., Epifanio, R., Horcajadas, J. A., Olivennes, F. J., Pellicer, A., & Simón, C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1160 · Cited by 25

Lower rate of early pregnancy loss in patients experiencing early-onset low LH in GnRH antagonist cycles supplemented with menotropin

Yang, P.-K., Wu, M., Chao, K., Chang, C., Chen, M., & Chen, S. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.01.012 · Cited by 24

Developmental exposure to a mixture of unconventional oil and gas chemicals: A review of experimental effects on adult health, behavior, and disease

Nagel, S. C., Kassotis, C. D., Vandenberg, L. N., Lawrence, B. P., Robert, J., & Balise, V. D. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110722 · Cited by 24

A prospective randomized study comparing gonadotropin-releasing hormone agonists or gonadotropin-releasing hormone antagonists in couples with unexplained infertility and/or mild oligozoospermia

Zikopoulos, K., Kaponis, A. I., Adonakis, G., Sotiriadis, A., Kalantaridou, S., Georgiou, I. A., & Paraskevaidis, E. A. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.060 · Cited by 24

Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian responders

Polyzos, N. P., Corona, R., van de Vijver, A., Blockeel, C., Drakopoulos, P., Vloeberghs, V., Vos, M. D., Camus, M., Humaidan, P., & Tournaye, H. J. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1065481 · Cited by 23

Recombinant follicle-stimulating hormone (rFSH) supplemented with low-dose human chorionic gonadotropin compared with rFSH alone for ovarian stimulation for in vitro fertilization

Horne, A. K. V., Bates, G. W., Robinson, R. D., Arthur, N. J., & Propst, A. M. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.12.051 · Cited by 23

Recombinant Luteinizing Hormone supplementation in poor responders undergoing IVF: a systematic review and meta-analysis

Fan, W., Li, S., Chen, Q., Huang, Z., Ma, Q., & Wang, Y. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2012.743016 · Cited by 22

The impact of luteinizing hormone in assisted reproduction: a review

Weghofer, A., Schnepf, S., Barad, D. H., & Gleicher, N. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3280bad843 · Cited by 22

Adjuvant gonadotrophin-releasing hormone agonist trigger with human chorionic gonadotrophin to enhance ooplasmic maturity

Pereira, N., Elias, R. T., Neri, Q. V., Gerber, R. S., Lekovich, J. P., Palermo, G. D., & Rosenwaks, Z. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.08.009 · Cited by 22

Early pregnancy loss in women stimulated with gonadotropin-releasing hormone antagonist protocols according to oral contraceptive pill pretreatment

Bellver, J., Albert, C., Labarta, E., & Pellicer, A. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.08.098 · Cited by 22

Effects of Urinary and Recombinant Gonadotropins on In Vitro Maturation Outcomes of Mouse Preantral Follicles

Park, K. E., Ku, S., Jung, K. C., Liu, H. C., Kim, Y. Y., Kim, Y. J., Kim, S. H., Choi, Y. M., Kim, J. G., & Moon, S. Y. (2012) · Reproductive Sciences · doi:10.1177/1933719112468948 · Cited by 21

Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist/FSH ovarian stimulation cycles

Ferrari, B., Pezzuto, A., Barusi, L., & Coppola, F. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.08.017 · Cited by 21

Medical Approaches to Ovarian Stimulation for Infertility

and, N. S. M., & Fauser, B. C. J. M. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00028-0 · Cited by 21

FSH and LH together in ovarian stimulation

Levi-Setti, P. E., Cavagna, M., Baggiani, A., Zannoni, E., Colombo, G. V., & Liprandi, V. (2004) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.01.013 · Cited by 20

Controlled ovarian stimulation with r-FSH plus r-LH vs. HMG plus r-FSH in patients candidate for IVF/ICSI cycles: An RCT

Tehraninejad, E. S., Taghinejad, M. F., Rashidi, B. H., & Haghollahi, F. (2017) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.29252/ijrm.15.7.435 · Cited by 23

The ratio of late-follicular to mid-follicular phase LH concentrations efficiently predicts ART outcomes in women undergoing ART treatment with GnRH-agonist long protocol and stimulation with recombinant FSH

Nakagawa, K., Ohgi, S., Nakashima, A., Horikawa, T., Sugiyama, R., & Saito, H. (2008) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-008-9243-0 · Cited by 20

Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG

Gomes, M. K. O., Vieira, C. S., de Moura, M. D., Manetta, L. A., Leite, S. P., dos Reis, R. M., & Ferriani, R. A. (2006) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.05.025 · Cited by 20

Tailoring FSH and LH administration to individual patients

Borini, A., & Prato, L. D. (2005) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60835-8 · Cited by 20

Gonadotrophins: The future

Patil, M. (2014) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.147490 · Cited by 19

Differences in serum LH and FSH levels using depot or daily GnRH agonists in controlled ovarian stimulation: influence on ovarian response and outcome of ART

Sonntag, B., Kiesel, L., Nieschlag, E., & Behre, H. M. (2005) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-005-5998-8 · Cited by 19

Early cessation of triptorelin in in vitro fertilization: A double-blind, randomized study

Simons, A., Roelofs, H. J. M., Schmoutziguer, A. P. E., Roozenburg, B. J., den Brink, E. P. V. H.-V., & Schoonderwoerd, S. A. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.10.044 · Cited by 19

Recombinant luteinizing hormone supplementation to recombinant follicle stimulating hormone therapy in gonadotropin releasing hormone analogue cycles: what is the evidence?

Younis, J. S., & Laufer, N. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1417827 · Cited by 18

LH receptor gene expression in cumulus cells in women entering an ART program

Papamentzelopoulou, M., Mavrogianni, D., Partsinevelos, G. A., Marinopoulos, S. S., Dinopoulou, V., Theofanakis, C., Anagnostou, E., & Loutradis, D. (2012) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-012-9729-7 · Cited by 18

The reproductive outcome of women with hypogonadotropic hypogonadism undergoingin vitrofertilization

Yılmaz, S., Ozgu-Erdinc, A. S., Yumuşak, Ö. H., Kahyaoğlu, S., Seçkin, B., & Yılmaz, N. (2015) · Systems Biology in Reproductive Medicine · doi:10.3109/19396368.2015.1037936 · Cited by 18

Single-dose depot leuprolide is as efficient as daily short-acting leuprolide in ICSI cycles

Isikoglu, M., Ozdem, S., Berkkanoğlu, M., Jamal, H., Şentürk, Z., & Ozgur, K. (2007) · Human Reproduction · doi:10.1093/humrep/dem054 · Cited by 18

Progestin‐primed ovarian stimulation with or without clomiphene citrate supplementation in normal ovulatory women undergoing in vitro fertilization/intracytoplasmic sperm injection: A prospective randomized controlled trial

Liu, Y., Chen, Q., Yu, S., Wang, Y., He, W., Chang, H. Y., Wang, B., Gao, H., Long, H., Wang, L., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13532 · Cited by 17

Clinical outcome of one-third–dose depot triptorelin is the same as half-dose depot triptorelin in the long protocol of controlled ovarian stimulation

Li, Y., Yang, D., & Zhang, Q. (2012) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.97785 · Cited by 16

A pharmacokinetic and endocrine comparison of recombinant follicle-stimulating hormone and human menopausal gonadotrophin in polycystic ovary syndrome

Balasch, J., Fábregues, F., Casamitjana, R., Peñarrubia, J., & Vanrell, J. A. (2003) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61848-2 · Cited by 16

Mild/minimal stimulation protocol for ovarian stimulation of patients at high risk of developing ovarian hyperstimulation syndrome

Rinaldi, L., Lisi, F., & Selman, H. A. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0021-1 · Cited by 16

Developments in drugs for ovarian stimulation

Ludwig, M. Z., Westergaard, L. G., Diedrich, K., & Andersen, C. Y. (2003) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/s1521-6934(02)00168-2 · Cited by 16

The potential value of mid-follicular phase LH

Filicori, M. (2002) · Human Reproduction · doi:10.1093/humrep/17.2.517-a · Cited by 16

The role of recombinant LH in ovarian stimulation: what’s new?

Alviggi, C., Vigilante, L., Cariati, F., Conforti, A., & Humaidan, P. (2025) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-025-01361-8 · Cited by 15

Efficacy of recombinantversushuman derived follicle stimulating hormone on the oocyte and embryo quality in IVF-ICSI cycles: Randomised, controlled, multi-centre trial

Abate, A., Nazzaro, A., Salerno, A., Marzano, F., Cossut, M. R. P., & Perino, M. (2009) · Gynecological Endocrinology · doi:10.1080/09513590902770156 · Cited by 15

Improved pregnancy rates with luteinizing hormone supplementation in patients undergoing ovarian stimulation for IVF

Paterson, N. D., Foong, S. C., & Greene, C. A. (2012) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-012-9740-z · Cited by 15

hMG increases the yield of mature oocytes and excellent-quality embryos in patients with a previous cycle having a high incidence of oocyte immaturity

Huddleston, H. G., Jackson, K. V., Doyle, J., & Racowsky, C. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.02.039 · Cited by 15

Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review

Krause, B. J. (2009) · Biologics · doi:10.2147/btt.2009.3306 · Cited by 15

Two approaches to improve fertility of subclinical mastitic dairy cows

Lavon, Y., Kaim, M., Leitner, G., Biran, D., Ezra, E., & Wolfenson, D. (2016) · Journal of Dairy Science · doi:10.3168/jds.2015-9745 · Cited by 15

Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization

Commenges-Ducos, M., Piault, S., Papaxanthos-Roche, A., Ribes, C., Dallay, D., & Commenges, D. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03372-1 · Cited by 15

Prospective Randomized Comparison of Ovarian Blockade with Nafarelin Versus Leuprolide During Ovarian Stimulation with Recombinant FSH in an ICSI Program

Franco, J. G., Jr., Baruffi, R. L. R., Mauri, A. L., Petersen, C. G., Chufallo, J. E., Felipe, V. A. D. A., & Garbellini, E. (2001) · Journal of Assisted Reproduction and Genetics · doi:10.1023/a:1013108921427 · Cited by 15

Does lower dose of long-acting triptorelin maintain pituitary suppression and produce good live birth rate in long down-regulation protocol for in-vitro fertilization?

Chen, X., Feng, S., Guo, P., He, Y., Liu, Y.-D., Ye, D.-S., & Chen, S. (2016) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-016-1569-8 · Cited by 14

The follicular-phase depot GnRH agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal GnRH agonist protocol: a single-centre, retrospective, propensity score matched cohort study

Zhang, Y., Zhao, W., Han, Y., Chen, X., Xu, S., Hu, Y., Diao, H., & Zhang, C. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-01014-0 · Cited by 14

To add or not to add LH: comments on a recent commentary

Humaidan, P. (2006) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60998-4 · Cited by 14

Is it necessary to monitor the serum luteinizing hormone (LH) concentration on the human chorionic gonadotropin (HCG) day among young women during the follicular-phase long protocol? A retrospective cohort study

Zhang, W., Liu, Z., Liu, M., Li, J., & Guan, Y. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-00888-4 · Cited by 13

Identification of common genetic polymorphisms associated with down-regulated gonadotropin levels in an exome-wide association study

Shi, Y., Miao, B., Ai, X., Cao, P., Gao, J., Xu, Y. L., Yang, Q., Fei, J., Zhang, Q., Mai, Q.-Y., et al. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.03.031 · Cited by 13

Stimulation ovarienne : la LH exogène est-elle nécessaire chez toutes les patientes ?

Loumaye, E. (2002) · Gynécologie Obstétrique & Fertilité · doi:10.1016/s1297-9589(02)00461-7 · Cited by 13

Conditional loss of ERK1 and ERK2 results in abnormal placentation and delayed parturition in the mouse

Brown, J. L., Sones, J. L., Angulo, C. N., Abbott, K., Miller, A. D., Boehm, U., & Roberson, M. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-45997-0 · Cited by 13

LH level on ovulation trigger day has a different impact on the outcomes of agonist and antagonist regimens during in vitro fertilization

Luo, X., Deng, B., Li, L., Ma, R., Mai, X., & Wu, Z. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01110-8 · Cited by 12

Anovulatory Patients Demonstrate a Sharp Decline in LH Levels upon GnRH Antagonist Administration during IVF Cycles

Segal, L., Fainaru, O., & Kol, S. (2017) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10298 · Cited by 12

Low Endogenous LH on the COS Initiation Day of a GnRH-Agonist Regimen Increases the Risk of Early Pregnancy Loss and Adverse ART Outcomes

Luo, X., Li, L., Lin, N., Ma, R., Li, Y., & Wu, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.830567 · Cited by 12

Luteinizing hormone supplementation in women with hypogonadotropic hypogonadism seeking fertility care: Insights from a narrative review

Segni, N. D., Busnelli, A., Secchi, M., Cirillo, F., & Levi-Setti, P. E. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.907249 · Cited by 12

Improving ovarian stimulation protocols for IVF in baboons: Lessons from humans and rhesus monkeys

Nyachieo, A., Spiessens, C., Mwenda, J. M., Debrock, S., & D’Hooghe, T. (2008) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2008.08.023 · Cited by 11

The evaluation of recombinant LH supplementation in patients with suboptimal response to recombinant FSH undergoing IVF treatment with GnRH agonist down-regulation

Yazıcı, F., Görkemli, H., Çolakoğlu, M. C., Aktan, M., & Gezginç, K. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.965675 · Cited by 12

Assessing predictors for the success of GnRH antagonist protocol in reproductive women in IVF/ICSI - in fresh cycles

Wang, A., Wang, Y., Wu, F., & Zhu, D. (2017) · Biomedical Reports · doi:10.3892/br.2017.984 · Cited by 11

Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction

Manna, C., Rahman, A., Sbracia, M., Pappalardo, S., Mohamed, E. I., Linder, R., & Nardo, L. G. (2005) · Gynecological Endocrinology · doi:10.1080/09513590400027141 · Cited by 12

Results from adding recombinant LH for assisted reproductive technology treatment: A randomized control trial.

Razi, M. H., Mohseni, F., Firouzabadi, R. D., Janati, S., Yari, N., & Etebary, S. (2014) · Europe PMC (PubMed Central) · Cited by 12

Efficacy of low dose hCG on oocyte maturity for ovarian stimulation in poor responder women undergoing intracytoplasmic sperm injection cycle: a randomized controlled trial

Madani, T., Yeganeh, L. M., Khodabakhshi, S., Akhoond, M. R., & Hasani, F. (2012) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-012-9854-3 · Cited by 11

GnRH agonist administration at the time of implantation does not improve pregnancy outcome in intrauterine insemination cycles: a randomized controlled trial

Bellver, J., Labarta, E., Bosch, E., de Melo, M. A. B., Vidal, C., Remohi, J. A., & Pellicer, A. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.04.044 · Cited by 11

Live-birth rates after HP-hMG stimulation in the long GnRH agonist protocol: association with mid-follicular hCG and progesterone concentrations, but not with LH concentrations

Arce, J., & Smitz, J. E. J. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.705379 · Cited by 11

The Role of LH in Ovarian Stimulation

Muñoz, E., Bosch, E., Fernández, I., Portela, S., Ortiz, G. M., Remohi, J., Sr., & Pellicer, A. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112799361945 · Cited by 11

Assisted reproduction technologies

Vatja, G., Callesen, H., Boe-Hansen, G. B., Hall, V. J., & Hyttle, P. (2010) · Cited by 11

Effect of gonadotropin-releasing hormone agonist and antagonist on steroidogenesis of low responders undergoing in vitro fertilization

Mohamed, K. A., Davies, W. A. R., & Lashen, H. (2006) · Gynecological Endocrinology · doi:10.1080/09513590500519260 · Cited by 11

Effect of halving the daily dose of triptorelin at the start of ovarian stimulation on hormone serum levels and the outcome of in vitro fertilization

Fábregues, F., Peñarrubia, J., Creus, M. T., Casamitjana, R., Vanrell, J. A., & Balasch, J. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.10.032 · Cited by 11

Association between serum LH levels on hCG trigger day and live birth rate after fresh embryo transfer with GnRH antagonist regimen in different populations

Zhou, R., Dong, M., Huang, L., Zhu, X., Wei, J., Zhang, Q., Liu, D., Zhang, X., & Liu, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1191827 · Cited by 10

The Role of LH in Controlled Ovarian Stimulation

Esteves, S. C., & Alviggi, C. (2015) · Springer eBooks · doi:10.1007/978-81-322-1686-5_16 · Cited by 10

Premature Progesterone Rise Positively Correlates with Clinical Pregnancy Rate in In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) Patients with good Ovarian Response

Cui, N., Zhang, J., Xu, Y., Jiang, L., Yang, A., & Hao, G. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-104384 · Cited by 10

The role of luteinizing hormone activity in controlled ovarian stimulation

Angelopoulos, N., Goula, A., & Tolis, G. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345534 · Cited by 10

Role of the endocrine profile for the achievement of pregnancy with IVF

Kolibianakis, E. M., Venetis, C. A., & Tarlatzis, B. C. (2009) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60447-6 · Cited by 10

Recombinant Gonadotropins

McClamrock, H. D. (2003) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-200306000-00009 · Cited by 10

Does HCG and LH supplementation during ovarian stimulation improve clinical outcome? An evaluation of 30 years of clinical research

Mannaerts, B. M. J. L., Andersen, C. Y., & Howles, C. M. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.104782 · Cited by 9

Mini-dose GnRH-a long versus short protocol in patients ≥35 years old undergoingin vitrofertilization

Xu, H., Ji, X., Yan, H., Zhu, Q., Zhao, X., & Sun, Y. W. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.906570 · Cited by 9

Administration of GnRH at Onset of Estrus, Determined by Automatic Activity Monitoring, to Improve Dairy Cow Fertility during the Summer and Autumn

Roth, Z., Kressel, Y. Z., Lavon, Y., Kalo, D., & Wolfenson, D. (2021) · Animals · doi:10.3390/ani11082194 · Cited by 9

Outcomes after early or midfollicular phase LH supplementation in previous inadequate responders

Sönmezer, M., Duvan, C. İ., Özmen, B., Taşçı, T., Özkavukçu, S., & Atabekoğlu, C. S. (2009) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2009.11.022 · Cited by 9

In-vivo ovarian androgen responses to recombinant FSH with and without recombinant LH in polycystic ovarian syndrome

Cheung, A. P. (2002) · Human Reproduction · doi:10.1093/humrep/17.10.2540 · Cited by 9

Profile of follitropin alpha/lutropin alpha combination for the stimulation of follicular development in women with severe luteinizing hormone and follicle-stimulating hormone deficiency

Rinaldi, L., & Selman, H. A. (2016) · International Journal of Women s Health · doi:10.2147/ijwh.s88904 · Cited by 9

Treatment of female infertility with recombinant human luteinising hormone: is there a benefit over other available drugs?

Shoham, Z. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.11.1985 · Cited by 9

Thicker endometrium on hCG trigger day improves the live birth rate of fresh cleavage embryo transfer in GnRH-agonist regimen of normogonadotrophic women

Luo, X., Li, Y., Zheng, H., Ding, L., Zhang, M., Li, Y., & Wu, Z. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-1922 · Cited by 8

The effect of rLH supplementation to the GnRH-antagonist protocol on endocrine dynamics in the advanced reproductive age

Younis, J. S., Izhaki, I., & Ben‐Ami, M. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0618-x · Cited by 8

Luteinizing hormone and human chorionic gonadotropin: a review of their varied clinical applications in assisted reproductive technology

Choi, J. M., & Smitz, J. E. J. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.969711 · Cited by 8

Role of LH in controlled ovarian stimulation.

Więsak, T. (2002) · PubMed · Cited by 8

Meta-analysis of recombinant FSH and urinary-derived gonadotrophins for IVF or ICSI

van Wely, M. (2003) · Human Reproduction · doi:10.1093/humrep/deg293 · Cited by 8

The forgotten variable: impact of luteinizing hormone on the prediction of ovarian reserve

Weghofer, A., & Feichtinger, W. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.06.059 · Cited by 8

The LH endocrine profile in gonadotropin-releasing hormone analogue cycles

Janssens, L., Roelant, E., & Neubourg, D. D. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2116424 · Cited by 7

Optimizing assisted reproduction: impact of low-dose gonadotropin-releasing hormone agonist on in vitro fertilization outcome

Lenton, E. A., & Mohamed, K. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.06.050 · Cited by 7

Effects of human menopausal gonadotropin on zona pellucida and pregnancy outcomes of ovarian stimulation protocols.

He, B., Jun-ping, C., Li, H., Tan, W., Xue, L., & Wang, S. (2015) · PubMed Central · Cited by 7

Recombinant luteinizing hormone priming in early follicular phase for women undergoing in vitro fertilization: Systematic review and meta-analysis

Hu, L., Bu, Z., Wang, K., & Sun, Y. (2014) · Journal of International Medical Research · doi:10.1177/0300060513509044 · Cited by 7

Optimizing GnRH antagonist administration: A meta-analaysis of fixed vs flexible protocol

Al-Inany, H. G., Al-Inany, H. G., Aboulghar, M. A., Mansour, R. T., & Serour, G. A. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.07.616 · Cited by 7

Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH

Balasch, J. (2001) · Human Reproduction · doi:10.1093/humrep/16.8.1636 · Cited by 139

Excessive LH Suppression During Controlled Ovarian Hyperstimulation the Influence of on Vitro Fertilization-embryo Transfer Outcome

Guo, H. (2002) · Journal of Practical Obstetrics and Gynecology

Ovarian response and pregnancy outcome related to midfollicular LH levels in down-regulated women undergoing assisted reproduction.

Ferrari, B., Barusi, L., Lanna, M. M., & Coppola, F. (2004) · PubMed · Cited by 8

Low Endogenous LH on the COS Initiation Day of a GnRH-Agonist Regimen Increases the Risk of Early Pregnancy Loss and Adverse ART Outcomes

Luo, X., Li, L., Lin, N., Ma, R., Li, Y., & Wu, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.830567 · Cited by 12

The relationship between pregnancy rate and suppression of luteinizing hormone in IVF-ET program.

Kim, J., Jung, D. Y., Jung, S. E., Lee, N. W., Kim, T., Kim, H. J., & Kim, S. H. (2005) · Obstetrics & Gynecology Science